The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis
The ability of pollutants to affect human health is a major concern, justified by the wide demonstration that reproductive functions are altered by endocrine disrupting chemicals. The definition of endocrine disruption is today extended to broader endocrine regulations, and includes activation of me...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2007-06, Vol.282 (26), p.19152 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The ability of pollutants to affect human health is a major concern, justified by the wide demonstration that reproductive
functions are altered by endocrine disrupting chemicals. The definition of endocrine disruption is today extended to broader
endocrine regulations, and includes activation of metabolic sensors, such as the peroxisome proliferator-activated receptors
(PPARs). Toxicology approaches have demonstrated that phthalate plasticizers can directly influence PPAR activity. What is
now missing is a detailed molecular understanding of the fundamental basis of endocrine disrupting chemical interference with
PPAR signaling. We thus performed structural and functional analyses that demonstrate how monoethyl-hexyl-phthalate (MEHP)
directly activates PPARγ and promotes adipogenesis, albeit to a lower extent than the full agonist rosiglitazone. Importantly,
we demonstrate that MEHP induces a selective activation of different PPARγ target genes. Chromatin immunoprecipitation and
fluorescence microscopy in living cells reveal that this selective activity correlates with the recruitment of a specific
subset of PPARγ coregulators that includes Med1 and PGC-1α, but not p300 and SRC-1. These results highlight some key mechanisms
in metabolic disruption but are also instrumental in the context of selective PPAR modulation, a promising field for new therapeutic
development based on PPAR modulation. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M702724200 |